Skip to content

Nipro PharmaPackaging International

Active
Public limited companyfounded 201511 yrs activeBlokhuisstraat 42, 2800 Mechelen, BelgiumKBO/BCE: BE 0636.806.780

Nipro PharmaPackaging International has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €191.42M and a net result of €-484k. Equity is growing by ~15.1% per year across the filed fiscal years. Its solvency ranks better than 66% of 6006 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.5% (very low).

Checked score

Score 2024
42 / 100
Weak▼ -42 vs 2023
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability0▼-65
Solvency88▼-7
Growth59▼-15
Stability100
Bankruptcy probability, 12 months
0.5% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €320k at 30 days only on tighter terms
Liquidity ample (current ratio 1.6 against 1.8 in 2023), and 44.3% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Five signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
55.7%
Return on assets
-0.1%
Age of the figures
20 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 04-07-2025, 27 days ahead of the deadline.
NBB · 9 filings
Deviation from the deadline
2025
not confirmed
2024
27 d early
2023
35 d early
2022
12 d early
2021
12 d early
2020
24 d early
2019
14 d early
← before the deadline after the deadline →
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, full schema

Turnover
€3.24M▲ 20.2%
2023 · €2.70M
2018: €1.69M 2019: €1.94M 2020: €1.65M 2021: €2.01M 2022: €1.99M 2023: €2.70M
2018 → 2024
EBIT margin
-1.5%▼ 20.1pp
2023 · 18.7%
2018: 5.5% 2019: 1.8% 2020: 8.3% 2021: 2.3% 2022: 6.5% 2023: 18.7%
2018 → 2024
Net result
€-484k
2023 · €587k
2018: €7k 2019: €-33k 2020: €111k 2021: €2.59M 2022: €137k 2023: €587k
2018 → 2024
Working capital
€56.93M▲ 15.8%
2023 · €49.17M
2018: €121k 2019: €40k 2020: €131k 2021: €-476k 2022: €8.19M 2023: €49.17M
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20202021202220232024Trend
Turnover€1.65M-€2.01M▲ 22.2%€1.99M▼ 0.8%€2.70M▲ 35.2%€3.24M▲ 20.2%
Equity€146.41M-€144.73M▼ 1.1%€178.82M▲ 23.6%€191.90M▲ 7.3%€191.42M▼ 0.3%
Operating result€137k-€45k▼ 66.8%€129k▲ 184%€503k▲ 291%€-48k
Net result€111k-€2.59M▲ 2,239%€137k▼ 94.7%€587k▲ 328%€-484k
Result per fiscal year
Operating resultNet result
€-1.00M€0€1.00M€2.00M€3.00MOperating result 2020: €137k€137kNet result 2020: €111k€111kOperating result 2021: €45k€45kNet result 2021: €2.59M€2.59MOperating result 2022: €129k€129kNet result 2022: €137k€137kOperating result 2023: €503k€503kNet result 2023: €587k€587kOperating result 2024: €-48k€-48kNet result 2024: €-484k€-484k20202021202220232024
The operating result turns negative in 2024: a loss of €48k after €503k in 2023, the lowest year so far.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €343.69M
Fixed assets €192.08M=
Current assets €151.62M▲ 37.0%
Equity and liabilities €343.69M
Equity €191.42M▼ 0.3%
Provisions €21k▲ 50.7%
Debt €152.25M▲ 37.4%
The debt ratio rises from 36.6% to 44.3%: debt grows while equity shrinks.
Key figures and ratios
2024 value · change against 2023
EBITDA
€-47k
2023 · €506k
Cash flow
€-483k
2023 · €589k
Solvency
55.7%
2023 · 63.4%
Current ratio
1.60
2023 · 1.80
Quick ratio
1.60
2023 · 1.80
Debt / equity
0.80
2023 · 0.58
ROE
-0.3%
2023 · 0.3%
ROA
-0.1%
2023 · 0.2%
Interest coverage
-0.01
2023 · 0.14
Debt
€152.25M
2023 · €110.81M
Debt ≤ 1 year
€94.69M
2023 · €61.48M
Debt > 1 year
€57.56M
2023 · €48.92M
Income taxes
€103k
2023 · €84k
Staff costs
€795k
2023 · €1.14M
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet Code20232024
Assets
Total assets20/58€302.73M€343.69M
Fixed assets21/28€192.08M€192.08M=
Intangible fixed assets21€699€384
Tangible fixed assets22/27€573-
Furniture and vehicles24€573-
Financial fixed assets28€192.07M€192.07M=
Affiliated companies280/1€192.07M€192.07M=
Participating interests280€192.07M€192.07M=
Current assets29/58€110.65M€151.62M
Amounts receivable after more than one year29€50.89M€68.81M
Other amounts receivable291€50.89M€68.81M
Amounts receivable within one year40/41€59.65M€82.66M
Trade receivables40€2.05M€2.19M
Other amounts receivable41€57.60M€80.47M
Cash at bank and in hand54/58€7k€93
Deferred charges and accrued income490/1€104k€151k
Equity and liabilities
Total equity and liabilities10/49€302.73M€343.69M
Equity10/15€191.90M€191.42M
Contributions10/11€188.48M€188.48M=
Capital10€188.48M€188.48M=
Issued capital100€188.48M€188.48M=
Reserves13€166k€166k=
Non-distributable reserves130/1€166k€166k=
Legal reserve130€166k€166k=
Profit (loss) carried forward14€3.26M€2.78M
Provisions and deferred taxes16€14k€21k
Provisions for liabilities and charges160/5€14k€21k
Pensions and similar obligations160€14k€21k
Amounts payable17/49€110.81M€152.25M
Amounts payable after more than one year17€48.92M€57.56M
Financial debts170/4€48.92M€57.56M
Other loans174€48.92M€57.56M
Amounts payable within one year42/48€61.48M€94.69M
Current portion of amounts payable after more than one year42€1.57M€13.36M
Trade debts44€2.00M€2.58M
Suppliers440/4€2.00M€2.58M
Taxes, remuneration and social security45€250k€246k
Taxes450/3€26k€41k
Remuneration and social security454/9€224k€206k
Other amounts payable47/48€57.67M€78.51M
Accrued charges and deferred income492/3€407k-
Income statement Code20232024
Operating income70/76A€11.37M€13.33M
Turnover70€2.70M€3.24M
Other operating income74€8.36M€10.09M
Non-recurring operating income76A€314k-
Operating charges60/66A€10.87M€13.38M
Services and other goods61€9.71M€12.52M
Remuneration, social security and pensions62€1.14M€795k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€887
Provisions for liabilities and charges: additions (uses and reversals)635/8€4k€7k
Other operating charges640/8€479€53k
Operating profit (loss)9901€503k€-48k
Financial income75/76B€3.85M€5.96M
Recurring financial income75€3.85M€5.96M
Income from current assets751€3.80M€5.96M
Other financial income752/9€44k€4k
Financial charges65/66B€3.68M€6.29M
Recurring financial charges65€3.68M€6.29M
Debt charges650€3.67M€6.01M
Other financial charges652/9€13k€287k
Profit (loss) for the period before taxes9903€670k€-381k
Income taxes67/77€84k€103k
Taxes670/3€84k€103k
Profit (loss) for the period9904€587k€-484k
Profit (loss) for the period to be appropriated9905€587k€-484k
Appropriation of the result
Profit (loss) to be appropriated9906€3.29M€2.78M
Profit (loss) brought forward from the previous period14P€2.70M€3.26M
Transfer to equity691/2€29k-
To the legal reserve6920€29k-
Social balance
Average headcount (FTE)90876.75.0

The notes to these accounts (42 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2026
21-08
State Gazette act Resignations & appointments
General meeting · Director resignation · Director appointment13 facts ▸
  • General meeting, 2026-07-16
  • Director resignation, Stephan Arnold (bestuurder)
  • Director appointment, Kresimir Secak (bestuurder)
  • Director appointment, Sensus Strategies BV (bestuurder)
  • Permanent representative, Serge Kemps
  • Mandate compensation, Kresimir Secak
  • Mandate compensation, Sensus Strategies BV
  • Mandate term, 6 jaar
  • Mandate term, 6 jaar
  • Board meeting, 2026-07-16
  • Director resignation, Stephan Arnold (gedelegeerd bestuurder)
  • Director appointment, Kresimir Secak (gedelegeerd bestuurder (CEO))
  • +1 further facts in this act
02-02
State Gazette act Resignations & appointments
Board meeting · Director reappointment · Mandate compensation11 facts ▸
  • Board meeting, 2025-06-19
  • Director reappointment, Stephan Arnold (dagelijks bestuurder)
  • Mandate compensation, Stephan Arnold
  • Director appointment, Stephan Arnold (gedelegeerd bestuurder)
  • General meeting, 2025-06-27
  • Auditor reappointment, onmiddellijk na de jaarvergadering van 2028, 2025-06-27
  • Permanent representative, Mieke Van Leeuwe
  • Director reappointment, Stephan Arnold (bestuurder)
  • Mandate compensation, Stephan Arnold
  • General meeting, 2025-09-23
  • Director resignation, Masanobu IWASA (bestuurder)
2025
04-07
NBB filing Annual accounts filed
fiscal year 2024 · full schema
12-05
State Gazette act Resignations & appointments
General meeting · Director resignation · Director appointment7 facts ▸
  • General meeting, 2024-06-24
  • Director resignation, Tsuyoshi YAMAZAKI (bestuurder)
  • Director resignation, Takehito YOGO (bestuurder)
  • Director appointment, Hideyuki NISHISAKO (bestuurder)
  • Mandate compensation, Hideyuki NISHISAKO
  • Director appointment, Masanobu IWASA (bestuurder)
  • Mandate compensation, Masanobu IWASA
2024
31-12
Financial Weakest financial yearnet €-484k ▼182%
Net result drops to €-484k, the lowest in the series.
26-06
NBB filing Annual accounts filed
fiscal year 2023 · full schema
15-04
State Gazette act Resignations & appointments
Sole-shareholder decision · Director reappointment · Mandate compensation3 facts ▸
  • Sole-shareholder decision, 2023-07-14
  • Director reappointment, Takehito YOGO (bestuurder)
  • Mandate compensation, Takehito YOGO
2023
19-07
NBB filing Annual accounts filed
fiscal year 2022 · full schema
16-05
State Gazette act Capital & shares · Statutes amendment
General meeting · Capital increase · Share issue5 facts ▸
  • General meeting, 2023-05-05
  • Capital increase, €12.500.000
  • Share issue, nieuwe aandelen, 12500000
  • Capital, €188.477.613
  • Power of attorney, Michel RAATS
2022
10-10
State Gazette act Resignations & appointments
General meeting · Auditor reappointment · Permanent representative3 facts ▸
  • General meeting, 2022-06-30
  • Auditor reappointment, commissaris, tot onmiddellijk na de jaarvergadering van 2025
  • Permanent representative, Filip Lozie
19-07
NBB filing Annual accounts filed
fiscal year 2021 · full schema
27-01
State Gazette act Capital & shares · Statutes amendment
General meeting · Capital increase · Share issue7 facts ▸
  • General meeting, 2022-01-21
  • Capital increase, €33.950.000
  • Share issue, a pari, 33950000
  • Capital, €175.977.613
  • Statutes amendment
  • Power of attorney
  • Power of attorney, Michel RAATS
2021
31-12
Financial Highest result since 2018net €2.59M ▲2239%
Net result €2.59M, the highest in the series.
05-10
State Gazette act Resignations & appointments
General meeting · Director reappointment · Mandate compensation3 facts ▸
  • General meeting, 2021-06-30
  • Director reappointment, Tsuyoshi YAMAZAKI (bestuurder)
  • Mandate compensation, Tsuyoshi YAMAZAKI
07-07
NBB filing Annual accounts filed
fiscal year 2020 · full schema
08-02
State Gazette act Capital & shares · Statutes amendment
General meeting · Capital increase · Bank account7 facts ▸
  • General meeting, 2021-01-29
  • Capital increase, €38.000.000
  • Bank account, bijzondere rekening op naam van de vennootschap bij BNP Paribas Fortis
  • Capital, €187.804.500
  • Statutes amendment
  • Statutes amendment
  • Power of attorney, Michel RAATS
2020
31-12
Financial Back to profitnet €111k
Net result €111k after one loss-making year.
31-12
Financial Equity above €100MEq €146.41M ▲72.7%
Equity rises from €84.76M to €146.41M.
17-07
NBB filing Annual accounts filed
fiscal year 2019 · full schema
13-05
State Gazette act Capital & shares · Statutes amendment
General meeting · Capital increase · Bank account4 facts ▸
  • General meeting, 2020-04-15
  • Capital increase, €29.039.000
  • Bank account, BNP Paribas Fortis, 2020-04-21
  • Capital, €149.804.500
17-04
State Gazette act Resignations & appointments
General meeting · Board meeting · Director resignation9 facts ▸
  • General meeting, 2020-04-01
  • Board meeting, 2020-04-01
  • Director resignation, Minoru TAKEUCHI (bestuurder)
  • Director resignation, Minoru TAKEUCHI (gedelegeerd bestuurder)
  • Director appointment, Stephan ARNOLD (bestuurder)
  • Mandate compensation, Stephan ARNOLD
  • Director appointment, Stephan ARNOLD (gedelegeerd bestuurder)
  • Mandate compensation, Stephan ARNOLD
  • Power of attorney, MVVP Advocaten
17-03
State Gazette act Resignations & appointments
General meeting · Director resignation · Director discharge7 facts ▸
  • General meeting, 2019-06-28
  • Director resignation, VRC Bedrijfsrevisoren CVBA (commissaris)
  • Director discharge, VRC Bedrijfsrevisoren CVBA
  • Auditor appointment, PWC BEDRIJFSREVISOREN BCVBA (commissaris)
  • Permanent representative, LOZIE Filip
  • Power of attorney, elk van de bestuurders afzonderlijk
  • Power of attorney, Minoru TAKEUCHI
07-02
State Gazette act Capital & shares · Statutes amendment
General meeting · Capital increase · Bank account6 facts ▸
  • General meeting, 2020-01-30
  • Capital increase, €32.500.000
  • Bank account, BNP Paribas Fortis
  • Statutes amendment
  • Corporate purpose, De vennootschap heeft tot voorwerp de productie van en handel in, de import en export en de aankoop en verkoop van medische producten, instrumenten of toestelle…
  • Capital, €120.765.500
2019
06-08
State Gazette act Resignations & appointments
Permanent representative1 fact ▸
  • Permanent representative, Geert Keunen
05-07
NBB filing Annual accounts filed
fiscal year 2018 · full schema
28-02
State Gazette act Resignations & appointments
General meeting · Director resignation · Director appointment4 facts ▸
  • General meeting, 2018-12-14
  • Director resignation, Koki OKAMOTO (bestuurder)
  • Director appointment, Takehito YOGO (bestuurder)
  • Mandate compensation, Takehito YOGO
2018
11-07
NBB filing Annual accounts filed
fiscal year 2017 · full schema
02-05
State Gazette act Resignations & appointments
General meeting · Director resignation · Director appointment8 facts ▸
  • General meeting, 2018-04-16
  • Director resignation, Kurt VAN DAL (gedelegeerd bestuurder)
  • Director appointment, Minoru TAKEUCHI (bestuurder)
  • Mandate compensation, Minoru TAKEUCHI
  • Board meeting, 2018-04-16
  • Director appointment, Minoru TAKEUCHI (dagelijks bestuurder)
  • Mandate compensation, Minoru TAKEUCHI
  • Director appointment, Minoru TAKEUCHI (gedelegeerd bestuurder)
01-03
State Gazette act Registered office
Board meeting · Registered-office move2 facts ▸
  • Board meeting, 2018-02-07
  • Registered-office move, Blokhuisstraat 42, 2800 Mechelen, BELGIË
2017
11-07
NBB filing Annual accounts filed
fiscal year 2016 · full schema
10-04
State Gazette act Resignations & appointments
General meeting · Director resignation · Director appointment6 facts ▸
  • General meeting, 2016-12-21
  • Director resignation, Keiichi KISAKIBARU (bestuurder)
  • Director appointment, Koki OKAMOTO (bestuurder)
  • Mandate compensation, Koki OKAMOTO
  • Approval, artikel 10 en elke andere clausule van de Master Loan Agreement
  • Power of attorney, RACINE
04-01
State Gazette act Resignations & appointments
Permanent representative1 fact ▸
  • Permanent representative, Brigitte Motte
2016
29-09
State Gazette act Miscellaneous
Correction of error1 fact ▸
  • Correction of error, Correctie van de datum van de buitengewone algemene vergadering van aandeelhouders van 22 december 2014 naar 22 december 2015 in de bekendmaking van het PV van…
01-09
State Gazette act Resignations & appointments
General meeting · Director resignation · Director appointment3 facts ▸
  • General meeting, 2016-05-26
  • Director resignation, Atsushi UDA (bestuurder)
  • Director appointment, Keiichi KISAKIBARU (bestuurder)
12-02
State Gazette act Resignations & appointments
Director appointment · Mandate compensation2 facts ▸
  • Director appointment, Kurt VAN DAL (gedelegeerd bestuurder)
  • Mandate compensation, Kurt VAN DAL
08-01
State Gazette act Algemene Vergadering - Boekjaar
General meeting · Statutes amendment · First fiscal year4 facts ▸
  • General meeting, 2015-12-07
  • Statutes amendment
  • First fiscal year, 2016-12-31
  • First annual meeting, 2017
07-01
State Gazette act Capital & shares
General meeting · Capital increase · Capital4 facts ▸
  • General meeting, 2015-12-22
  • Capital increase, €88.204.000
  • Capital, €88.265.500
  • Power of attorney, Bestuurders
2015
16-09
State Gazette act Incorporation
Incorporation · Founder · Corporate purpose16 facts ▸
  • Incorporation, 2015-08-31
  • Founder, Kurt VAN DAL
  • Founder, Nipro Europe Group Companies
  • Corporate purpose, De vennootschap heeft als hoofddoel de productie van en handel in, de import en export en de aankoop en verkoop van medische producten, instrumenten of toestell…
  • Founding capital, €61.500
  • Bank account, MIZUHO BANK NEDERLAND NV
  • Director appointment, Kurt VAN DAL (bestuurder)
  • Director appointment, Tsuyoshi Yamazaki (bestuurder)
  • Director appointment, Atsushi Uda (bestuurder)
  • Mandate compensation, Kurt VAN DAL
  • Mandate compensation, Tsuyoshi Yamazaki
  • Mandate compensation, Atsushi Uda
  • +4 further facts in this act
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
11 directors, no change since 2026
Kresimir Secak
Director · since 16-07-2026
Current
Sensus Strategies
Director · since 16-07-2026 · Private limited company · perm. rep.: Serge Kemps
Current
Takehito YOGO
Director · since 14-07-2023
Current
Tsuyoshi YAMAZAKI
Director · since 30-06-2021
Current
16-07-2026 Kresimir Secak: Appointed as Director
16-07-2026 Kresimir Secak: Appointed as Gedelegeerd bestuurder (ceo)
16-07-2026 Sensus Strategies: Appointed as Director
16-07-2026 Stephan Arnold: Resigned as Managing director
16-07-2026 Stephan Arnold: Resigned as Director
23-09-2025 Masanobu IWASA: Resigned as Director
24-06-2024 Takehito YOGO: Resigned as Director
24-06-2024 Tsuyoshi YAMAZAKI: Resigned as Director
14-07-2023 Takehito YOGO: Mandate renewed as Director
30-06-2021 Tsuyoshi YAMAZAKI: Mandate renewed as Director
01-04-2020 Minoru TAKEUCHI: Resigned as Director
01-04-2020 Minoru TAKEUCHI: Resigned as Managing director
17-12-2018 Koki OKAMOTO: Resigned as Director
01-05-2018 Kurt VAN DAL: Resigned as Managing director
22-12-2016 Keiichi KISAKIBARU: Resigned as Director
01-09-2016 Atsushi UDA: Resigned as Director
12-01-2016 Kurt VAN DAL: Appointed as Managing director
Location & real-estate footprint
Registered office, Mechelen · 1 establishment unit since 2016
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Blokhuisstraat 422800 Mechelen
Ground area
1.3 ha
Building footprint
2,067 m²
Volume, LiDAR
17,901 m³
Parcel 12402A0113/00Y000, Flanders · tallest building 9.9 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Nipro PharmaPackaging International
Blokhuisstraat 42, 2800 MechelenWholesale trade
since 20162.248.594.216
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
12402A0113/00Y000 Flanders 1.3 ha 1 · 2,067 m² 9.9 m · 3 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Statutory auditor

3 auditors
PricewaterhouseCoopers Reviseurs d'EntreprisesCurrent
Statutory auditor · represented by Filip Lozie
30-06-2022 → present
Show 2 earlier auditors
PWC Bedrijfsrevisoren BCVBA
Statutory auditor · represented by LOZIE Filip
succeeded by PricewaterhouseCoopers Reviseurs d'Entreprises in 2022
28-06-2019 → 30-06-2022
VRC BEDRIJFSREVISOREN
Statutory auditor
- → 28-06-2019

Structure & network

Connections & network

3 connected companies

Ownership & control

1 party
Control over this companysits on this company's board1
1 subsidiary · 1 location
controls
Nipro PharmaPackaging InternationalBE 0636.806.780

Similar companies · same sector, comparable size

Of 61 companies in sector 46441 we hold annual accounts for 40. 1 is within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPublic limited company
Founded07-09-2015
Fiscal year end31-12
Activities, NACEBEL
46441Wholesale trade
46460Wholesale of pharmaceutical and medical goods
46450Wholesale of perfume and cosmetics
46492Wholesale trade
46900Non-specialised wholesale trade
Sources
Crossroads Bank for EnterprisesNational Bank · 9 filingsAddress and cadastre registers

Data from official sources, last processed on 12-09-2026. Scores and ratios are computed by Checked and are not a credit decision.